Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.67 |
| ▸ | CHRNB4 | P30926 | 6/20 | 0.67 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.67 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.67 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.67 |
| ▸ | CHRNA1 | P02708 | 4/20 | 0.67 |
| ▸ | CHRNG | P07510 | 4/20 | 0.67 |
| ▸ | CHRNB1 | P11230 | 4/20 | 0.67 |
| ▸ | CHRND | Q07001 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28360223 | 1.00 | SLC6A2 (0.67) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| Hydrochloric Acid SCHEMBL28057449 | 0.98 | SLC6A2 (0.65) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| SCHEMBL1072701 | 0.98 | SLC6A2 (0.69) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| Hydrochloric Acid SCHEMBL22614730 | 0.98 | SLC6A2 (0.65) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| Bromide SCHEMBL13729160 | 0.96 | SLC6A2 (0.68) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| Hydrochloric Acid SCHEMBL10728832 | 0.96 | SLC6A2 (0.68) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| SCHEMBL1714913 | 0.84 | SLC6A2 (0.50) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| SCHEMBL4869220 | 0.84 | OPRD1 (0.53) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| SCHEMBL4818799 | 0.84 | CYP2D6 (0.67) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 | |
| SCHEMBL321368 | 0.84 | ALDH1A1 (0.67) | SLC6A2SLC6A3CHRNB4CHRNA3CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2026-03-26 | — | — | US | claimed |
| CN-117110457-A | Analysis method for screening 50 new pollutants in sewage by micro-volume direct sample injection technology | 司法鉴定科学研究院 | 2023-11-24 | — | — | CN | claimed |
| CN-117018186-A | Construction method and application of transgenic mouse model with osteoclast Spp1 gene deleted | 中国人民解放军陆军军医大学第二附属医院 | 2023-11-10 | — | — | CN | claimed |
| US-20230054132-A1 | DNA APTAMER-CYANINE COMPLEXES AS GENERIC COLORIMETRIC SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-02-23 | — | — | US | claimed |
| CN-112441888-A | Pd-ReOx/CeO2Method for preparing nitrogen-containing aromatic compound by catalyzing lignin ammoniation reaction | 中国科学院大连化学物理研究所 | 2021-03-05 | — | — | CN | claimed |
| US-9671415-B2 | Immunoassay for pyrrolidinophenones | RANDOX LABORATORIES LIMITED (GB) | 2017-06-06 | — | — | US | claimed |
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2026-03-26 | — | — | US | disclosed |
| CN-120241646-A | Nanometer carrier system for targeting aging alveolar epithelial cells and preparation method and application thereof | 浙江树人学院 | 2025-07-04 | — | — | CN | disclosed |
| CN-119968208-A | Compositions and methods for treating actinomycetes infections | 安度利体技术公司 | 2025-05-09 | — | — | CN | disclosed |
| US-11912705-B2 | Cathinone derivatives, pharmaceutical formulations, and methods | THE CORPORATION OF MERCER UNIVERSITY (US) | 2024-02-27 | — | — | US | disclosed |
| US-20240053291-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-02-15 | — | — | US | disclosed |
| CN-117110457-A | Analysis method for screening 50 new pollutants in sewage by micro-volume direct sample injection technology | 司法鉴定科学研究院 | 2023-11-24 | — | — | CN | disclosed |
| CN-117018186-A | Construction method and application of transgenic mouse model with osteoclast Spp1 gene deleted | 中国人民解放军陆军军医大学第二附属医院 | 2023-11-10 | — | — | CN | disclosed |
| US-20160097783-A1 | IMMUNOASSAY FOR PYRROLIDINOPHENONES | NORTHERN BANK LIMITED (IE) | 2016-04-07 | — | — | US | disclosed |
| US-20160097783-A1 | IMMUNOASSAY FOR PYRROLIDINOPHENONES | NORTHERN BANK LIMITED (IE) | 2016-04-07 | — | — | US | disclosed |
| EP-3002592-A1 | IMPROVED IMMUNOASSAY FOR PYRROLIDINOPHENONES | Randox Laboratories Ltd. (GB) | 2016-04-06 | — | — | EP | disclosed |
| WO-2015063795-A2 | NOVEL PROCESS FOR PREPARATION OF OPTICALLY PURE NOREPHEDRINE AND ITS DERIVATIVES | LAURUS LABS PRIVATE LIMITED (IN) | 2015-05-07 | — | — | WO | disclosed |
| EP-0150235-A1 | Derivatives of 3-pyrrolidinopropiophenone and a process for preparation thereof | Hokuriku Pharmaceutical Co.,Ltd (JP) | 1985-08-07 | — | — | EP | disclosed |
| US-4361573-A | α,α-Diaryl-β-(tert-amino)-propanols and diuretic pharmaceutical compositions containing them | TEMMLER AG (CH) | 1982-11-30 | — | — | US | disclosed |
| US-4025633-A | DIURETICS, SALURETICS | FIRMA TEMMLER A.G. (CH) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160097783-A1 | IMMUNOASSAY FOR PYRROLIDINOPHENONES | CYP2D6, CYP2B6, CYP3A43 | SLC6A2 1912/4885SLC6A3 690/4885CHRNB4 4520/4885 |
| US-11912705-B2 | Cathinone derivatives, pharmaceutical formulations, and methods | TACR2, TACR1, ADRA2C | SLC6A2 99/4885SLC6A3 157/4885CHRNB4 267/4885 |
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | EBPL, ADA, XBP1 | SLC6A2 261/4885SLC6A3 186/4885CHRNB4 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.